Barclays Maintains an 'Overweight' on Aetna (AET) After Hosting Meeting with Management
Tweet Send to a FriendGet Alerts AET Hot Sheet
Price: $62.23 -0.67%
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Trade AET Now!
Barclays maintains an 'Overweight' on Aetna (NYSE: AET) price target of $59.00.
Analyst, Joshua R. Raskin, said, "Since it reported first quarter 2012 earnings on April 26, 2012, shares of AET have declined 15.9% (with the broader market down 3.8%). Clearly, the quarter was not well received. The company has also had the chance to meet with several groups of investors over the past two weeks and is presenting at a competitor conference this week. After spending the day with the company, we concluded that investors simply won't gain comfort in the year until there is a better read on 2Q12 results."
Raskin continues to be bullish on shares, confident in assets, acceleration in medical costs, and current valuation of AET is under 8x 2013 EPS estimates.
For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.
Shares of Aetna closed at $41.53 yesterday, with a 52 week range of $33.43-$51.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Joshua R. Raskin, said, "Since it reported first quarter 2012 earnings on April 26, 2012, shares of AET have declined 15.9% (with the broader market down 3.8%). Clearly, the quarter was not well received. The company has also had the chance to meet with several groups of investors over the past two weeks and is presenting at a competitor conference this week. After spending the day with the company, we concluded that investors simply won't gain comfort in the year until there is a better read on 2Q12 results."
Raskin continues to be bullish on shares, confident in assets, acceleration in medical costs, and current valuation of AET is under 8x 2013 EPS estimates.
For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.
Shares of Aetna closed at $41.53 yesterday, with a 52 week range of $33.43-$51.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Goldman Sachs Upgrades Mizuho Financial Group Inc. (MFG) to Buy
- UPDATE: UBS Starts Insmed (INSM) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Barclays, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
